chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; sore arms started 3 hours after the vaccine; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Mar2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included mild gastritis and allergy to shellfish. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included minerals nos, vitamins nos (CENTRUM), vitamin d nos (MANUFACTURER UNKNOWN) and ferrous sulfate (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient previously received oxycodone hydrochloride (CODIN) on unknown date for unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Mar2021 at 17:30, 3 hours after the vaccine, the patient experienced sore arms. On 11Mar2021 at 12:00, around noon, the patient experienced headache. On 12Mar2021, around noon, again the patient experienced headache. On 13Mar2021, from noon to night and on 14Mar2021, in the evening, the patient experienced headache. On 15Mar2021 from around 16:00 to evening, the patient experienced headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with paracetamol (TYLENOL) on 15Mar2021 around 19:00. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arms and headache was recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced NAUSEA (Nausea). At the time of the report, NAUSEA (Nausea) outcome was unknown. Not Provided          No Concomitant information  provided. No Treatment information  provided
A few hours after I received the vaccine I started to get a headache that lasted until I went to bed. When I woke up the next morning my head still hurt and my whole body ached. This lasted until I went to bed that night. When I woke up in the morning all symptoms were gone and I felt completely fine.
received 1st injection on 10/28/2020  and shingles appeared on 11/30/2020 received 2nd injection on 1/19/2021 and shingles appeared  on 9/15/2021 shingles 1st appeared on 3/15/2020
Dx 3/4/06 with chickenpox with lesions on face, upper trunk and lower back. Tx tylenol 320 mg PO 4 hr PRN T > 101.0 benadryl 12.5 mg PO TID PRN calamine lotion
miss my second appointment for the second dosis; Miss my second appointment for the second dosis; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Miss my second appointment for the second dosis) and PRODUCT DOSE OMISSION ISSUE (miss my second appointment for the second dosis) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Miss my second appointment for the second dosis) and PRODUCT DOSE OMISSION ISSUE (miss my second appointment for the second dosis). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Miss my second appointment for the second dosis) and PRODUCT DOSE OMISSION ISSUE (miss my second appointment for the second dosis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided  No treatment medications provided   Reporter did not allow further contact
Information has been received from a 65 year old female registered nurse with no pertinent medical history or drug reactions or allergies reporting herself who on 17-APR-2009 was vaccinated IM instead of SC with the first dose of ZOSTAVAX (Merck) into the left deltoid. Concomitant therapy included vitamins (unspecified). On 18-APR-2009 her left arm became a little sore. On the same day, the patient recovered. No lab tests were done. The patient did not seek medical attention. Additional information has been requested.
Patient immediately began shaking and then passed out. Didn't remember anything afterwards. The doctor stated this vaccine is recommended for ALL teens and is very critical to receive. That is untrue based on what I have read. I am VERY upset.
2nd Vaccination on 4/13/21. On 4/14, I woke up to a bruise at injection site size of a nickel.  Within 2? of injection I have a large welp that is red, swollen, and hot to the touch, and hurts to touch. Arm hurts to move.
Client received their 2nd dose of Pfizer vaccine that was mixed on 9/1/21 @ 0906 and was given to client 20-25 minutes after 6 hour time expired 1506. Client felt fine at time of receiving vaccine. Today 9/2/21 @ 1013 writer spoke with client to report dose valid and not to be repeated. Client states feeling fine today, no concerns. Appreciative of conversations yesterday & today. No adverse reaction.
light headed; Felt very cold; Every time they coughed they had a pain in their head; Nauseous; Extremely tired; Headache was stronger were they couldn't open their eyes; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (light headed), FEELING COLD (Felt very cold), COUGH (Every time they coughed they had a pain in their head), NAUSEA (Nauseous) and FATIGUE (Extremely tired) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced DIZZINESS (light headed), FEELING COLD (Felt very cold), COUGH (Every time they coughed they had a pain in their head), NAUSEA (Nauseous), FATIGUE (Extremely tired) and HEADACHE (Headache was stronger were they couldn't open their eyes). At the time of the report, DIZZINESS (light headed), FEELING COLD (Felt very cold), COUGH (Every time they coughed they had a pain in their head), NAUSEA (Nauseous), FATIGUE (Extremely tired) and HEADACHE (Headache was stronger were they couldn't open their eyes) outcome was unknown.            No concomitant medication information was provided.  After the second dose patient couldn't lay on their side.  No treatment medication were provided.   This case was linked to MOD-2021-283875 (Patient Link).
Patients date of birth was miscalculated. Moderna was selected and given as a booster shot to the patient who was at the age of 17 years and 10  months old at the time of vaccination.
Following my son's MMR and DTP vaccinations, he lost speech, social skills and eventually developed autism. I reported the initial gastric problems and fever to the nurse, but was told this was probably unrelated and I was advised to give pedialyte. I have bideo of him on his 1st birthday waving, pointing and saying "Hi, gradma," "hi, grandpa."
swollen glands in neck, painful and large, sore throat, headache, congestion, flu like symtpoms
1 minute, post vax, client started to itch and develop hives on his back and abdomen. No shortness of breath or facial swelling, no wheezes, color pink. BP-120/70; P-84; R-18.
This event was caused by human error. The nurse inadvertently administered the Moderna Bivalent dose to patient instead of the primary dose. Patient was monitored for 15 minutes and did not show any adverse side effects. The patient did not have access to a cell phone. A message was left for the director on 10/15/2022 to follow-up on the patient however, a callback was never received.
My husband was feeling ill on 03/28/2023. We both tested for COVID-19 at that time. I was negative, he was positive. I wasn't feeling much of anything at that point. On 03/29/2023, I thought I might be developing a sore throat but dismissed it. By 03/30/2023, I could tell that I was coming down with something. I tested again for COVID-19. I called my doctor and did a telehealth visit and was prescribed Paxlovid. I had a slight fever, swollen glands. Initially, it was just a slight sore throat, but it progressed into a very severe sore throat that was worse than when I had strep throat when I was young. That lasted for around two days or sore. I'm still feeling a bit of a sore throat this morning, but not nearly anywhere as severe.
About 2 hrs /p shot was given pt began crying-trembling-had episode of prolonged crying.
This is a spontaneous report from a contactable nurse.  An 8-week-old female patient received PREVNAR 13 (lot number: T78675 and expiration date: 01Mar2020) intramuscular in the left thigh on 05Jul2018 12:10 at 0.5 ml, single for routine vaccination. The patient had no relevant medical history and no known allergies. Family medical history was unknown. The patient had no vaccinations within 4 weeks prior to the administration of  pneumococcal 13-valent conjugate vaccine. Concomitant medication included the first dose of ROTARIX (lot number: HS35D and expiration date: 17Oct2019) oral, also given on 05Jul2018 for immunization. It was reported that they first gave the rotavirus vaccine live oral 1v, orally, and then they gave the pneumococcal vaccine in the left leg. Immediately after the injection on 05Jul2018, the patient experienced swelling and bleeding at injection site and was crying. Severity of the swelling and bleeding at injection site was unknown. They showed the doctorand he said no more injections for now. They called the parents back about 3 hours later and stated that the patient didn't cry for long, and they applied ice to the swelling, and it went down. The patient fell asleep on the way home and had no fevers. The events did not require and emergency room or physician office visit. No other concomitant medications, medical history, or relevant testing or investigations were provided at the time of the report. Outcome of the events was recovered on the same day, 05Jul2018. The reporter wanted to know if there were any recommendations for future vaccinations.
Experienced swelling in ankles, feet, legs and knees beginning Friday evening 1/15/20.   Trying to determine if this is a covid vaccine reaction.  Last dose of nasal spray was Saturday evening, 01/16/20.  Since then, swelling is slowly resolving.  Reports symptoms to Hospital.  Getting Covid tested again today.
Patient fainted and fell to the ground within minutes after the flu shot. Patient was discovered when he stood up from the fall outside of the pharmacy drop-off area with bloody nose, few lacerations, and a missing tooth. Pharmacist assessed patient and he said he was fine. Pharmacy staff and store staff helped patient cleaned up and was feeling fine when Aunt came to pick patient up about 25 minutes later.
My husband had fever of 102.6 the morning after he received the vaccine. He continued to run high fever. He had gi symptoms with diarrhea. He was up all Saturday night with generalized body aching  and diarrhea. On Sunday night he coded in the bathroom at home. CPR was started when EMS arrived he was in full cardiac arrest. He was coded for 1 hour without any return of heart function. I found my husband on the bathroom floor on that Sunday night about 1140pm performed CPR and activated 911.
ARMS WERE HURTING; HEADACHE; EXHAUSTED; PAIN IN THE ARM AT THE SITE OF INJECTION; SOME LOWER BACK PAIN; This spontaneous report received from a health care professional concerned a 57 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 03-SEP-2021 09:30 for prophylactic vaccination. No concomitant medications were reported.  On SEP-2021, the patient experienced some lower back pain. On SEP-2021, the patient experienced pain in the arm at the site of injection. On 03-SEP-2021, the patient experienced headache. On 03-SEP-2021, the patient experienced exhausted. On 04-SEP-2021, the patient experienced arms were hurting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, and exhausted on 03-SEP-2021, and the outcome of some lower back pain, pain in the arm at the site of injection and arms were hurting was not reported. This report was non-serious. This case, from the same reporter is linked to 20210924065.
Intense lower extremity rash; This non-serious case was reported by a consumer and described the occurrence of rash in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included hypothyroidism. Concomitant products included levothyroxine.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced rash (Verbatim: Intense lower extremity rash). The outcome of the rash was resolved.   It was unknown if the reporter considered the rash to be related to Shingrix.     It was unknown if the company considered the rash to be related to Shingrix.   Additional Information: GSK Receipt Date: 24-JUN-2023. This report was submitted. This report was submitted via the online direct entry reporting system. Please process using the related SOP. This report was submitted by site public reporting. The patient was not pregnant. The patient was the reporter. Reporter seriousness for Intense lower extremity rash was intervention required The reporter consented to follow up.
diarrhea and it was just all bright red fresh blood/bright red blood with diarrhea; bright red blood coming from her anal area; feel heaviness, she just feels that heaviness.; she lost weight; This is a spontaneous report from a contactable consumer (patient). A 81-year old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE lot number EM9809) (at the age of 81-years-old), via an unspecified route of administration on 06Feb2021 between 12:30 and 1PM as a single dose for covid-19 immunization.  The facility where COVID-19 vaccine was a doctor's office and administered anatomically located on the right arm. The patient medical history included: She has been diagnosed years ago 10 years ago, which was since she smoked with COPD and she is on breathing medication, but she has not had it due to getting in a donut hole with insurance and she cannot afford it, her hands also won't let her use it, She hasn't had it for 2 months. Arthritis. She has had no other vaccines on the same day or in the past 4 weeks, she had the flu shot back in Oct2020. Family Medical History: Her dad had heart problems and cancer. Her brother had cancer. Her mother had heart conditions. Concomitant medications included: Acetaminophen and Naproxen sodium. She was taking a lot of acetaminophen and Naproxen sodium for arthritis pain, but she has not had any since Friday night 05Feb2021. She did not want to take anything before the shot. She hasn't been weighed in a while, she lost weight. On 06Feb2021, at 8 o clock on the night, she experienced bright red blood coming from her anal area; then, she had diarrhea and it was just all bright red fresh blood, it was fresh new blood not dark at all. Today she is still having bright red blood with diarrhea; the blood seems like it is decreasing, it's being colored by diarrhea. She felt maybe in so many years is like when you have a period at times and feel heaviness, she just feels that heaviness. Caller reports that she does have a standing appointment with her provider tomorrow. The clinical outcome of the events bloody diarrhea and anal bleeding was not recovered, heaviness and weight decreased was unknown. She is scheduled for the second dose on 10Feb2021.
The day following the injection, I began to experience hypertension and  an accelerated heart beat.  It was sustained at 140/100 and a pulse of 100, with an associated headache and dizziness. I also felt tightness in my chest. I do not have hypertension and usually my blood pressure is 125/80 with a pulse of 70.  I was not exerting myself at the time of occurrence.  This continued on and off for the next  2 days, prompting me to visit my doctor?s office.  Symptoms subsided  3 days after starting.
Sudden diarrhea; This is a spontaneous report from a contactable consume (patient). A 84-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown) via an unspecified route of administration in right arm on 03Feb2021 at 09:45 as single dose for COVID-19 immunization. Medical history included chronic kidney disease. Concomitant medications included Symbicort, Montelukast SOD, Terazosin, Famotidine. Historical vaccine included BNT162B2 (Lot unknown=False, Dose number=1) for COVID-19 immunization. On 05Feb2021, the patient experienced sudden diarrhea. Outcome of the event was recovered on an unspecified date 2021.  Information about lot/batch number requested.
Childs Left leg appeared swollen and red. So brought child in for appt. on 4/21/11.  Seemed to be getting better, no treatment advised, only local reaction of injection site noted.
pt's mom states pt broke out in a rash on 11JUN93; states it was worse on rt arm but also present on lt arm,chest, back, buttocks & ankles; pt has been given DPH & applying cortisone cream to rash; itching;
I got the moderna spikevax and my seasonal flu shot at the same time in my arm. I woke up with vertigo at 3:22 am the next day and it has not gone away almost three days later. I have never had vertigo.
J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/29/2022 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/29/2022 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE
This patient had pain of the right arm consistent with reflex sympathetic dystrophy, onset within hours of shot. Course expected to be prolonged. Prescription: Analgesics, including narcotics, Neuroleptics. Ongoing patient needed. Evaluation at tertiary care center.
Headache lasting 36 hours. Heavy menstrual cycle on the day after receiving the vaccine. I had to change my tampon every 2 hours.
Patient stated that the site of his pneumovax shot is red and warm. Started a couple of days after shot He stated he is sensitive to shots. Will keep an eye on it and use a cold pak.
19FEB99 parent reported child stopped breathing, color pale & dusky, body became stiff;appeared to be sz;parent performed CPR,ambulance treated & transported to ER;pt hosp 5 days;another sz occurred 20FEB99;placed on phenobarb;
On 5/24 mother reports that child was wheezing, coughing, and had pain.  On 5/25/04 mother states that childs left arm was swollen all of the way to the wrist, with redness, itching, and pain.  Mother took child to physician on 5/26/04 and child started on antibiotics.
severe arthralgia; pleuritic pain; confusion; making stupid mistakes; myalgia; upset stomach; fever of approximately 100 degrees; chills; shakes; feeling weak; unable to get out of bed; This case was reported by a physician via call center representative and described the occurrence of myalgia in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of myalgia (after receiving 1st dose, see case US2019AMR166034).   On 3rd September 2019, the patient received the 2nd dose of Shingrix. On 3rd September 2019, less than a day after receiving Shingrix, the patient experienced myalgia, upset stomach, fever, chills, tremor and feelings of weakness. On an unknown date, the patient experienced arthralgia, pleuritic pain, bedridden, confusion and behavior abnormal. On an unknown date, the outcome of the myalgia, upset stomach, fever, chills, tremor, arthralgia, pleuritic pain, bedridden, confusion and behavior abnormal were recovered/resolved and the outcome of the feelings of weakness was not recovered/not resolved.   It was unknown if the reporter considered the myalgia, upset stomach, fever, chills, tremor, feelings of weakness, arthralgia, pleuritic pain, bedridden, confusion and behavior abnormal to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The batch number of Shingrix vaccine was not reported. The physician reported that, approximately 10 am on 3rd Septrember 2019, the patient received 2nd dose of Shingrix. After vaccination, the patient developed severe arthralgia, pleuritic pain, which described as pain on inhalation. The reporter reported that, the patient could not get out of bed for almost 2 days and also mentioned that, during those two days post vaccination experienced confusion, and making stupid mistakes on the computer. The confusion described as telling her son the same things more than once. The patient had fever of approximately 100 degrees. The patient stated that, at the time of reporting, the symptoms were recovered, but stii had feeling weak. The reporter consented to follow up. No further details were provided.
began w/fever of 102 R on 28AUg93 APAP given; 29AUG93 felt warm to touch gave APAP 5PM; both days diet appetite elimination activity per nl; 29AUG93 started staring & then went into a grandmal sz lasting 1-2 mins; no cyanosis noted;
PATIENT TESTED POSITIVE FOR COVI 19 ON 04/29/2021
7 - 14 days post vax, the pt developed skin lesions at spots other than the injection site..
This case was reported by a healthcare professional via a sales representative and described the occurrence of not responding to therapy in an adult male subject who was vaccinated with Engerix B (manufacturer unspecified) for prophylaxis.  On an unspecified date the subject received unspecified dose of Engerix B vaccine (unknown).  At an unspecified time after vaccination with Engerix B vaccine, the subject experienced not responding to therapy.  At the time of reporting the outcome of the event was unspecified.  Follow-up information received on 13 June 2007 indicated that the subject was 30 years old at the time of the event.  In the reporter's opinion, the event was related to treatment with Engerix B vaccine.  The subject tested Hepatitis B surface antibody negative.  Outcome was not stated.
Case noted with increasing difficulty walking and writing.  Once case noted with difficulty speaking s/o transported to hospital. Hospital dx CVA. Case now resides at LTC permanently.